Assignee
MIMETOGEN PHARMACEUTICALS INC
CA·7 granted patents·13 citations·filing 2013–2023
Top patents by PatentIndex Score
7 records- 0191US11753441B2Solution phase synthesis of beta-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2021·Granted Sep 12, 2023·2 cites·20 claims
- 0290US11078234B2Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 3, 2021·4 cites·21 claims
- 0385US10125165B2Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2016·Granted Nov 13, 2018·3 cites·12 claims
- 0478US12281179B2Solution phase synthesis of β-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2023·Granted Apr 22, 2025·0 cites·1 claims
- 0574US9156882B2Beta-turn peptidomimetic cyclic compounds for treating dry eyeMIMETOGEN PHARMACEUTICALS INC·Filed 2014·Granted Oct 13, 2015·2 cites·4 claims
- 0670US9115179B2Synthesis of beta-turn peptidomimetic cyclic compoundsMIMETOGEN PHARMACEUTICALS INC·Filed 2013·Granted Aug 25, 2015·2 cites·54 claims
- 0751US9707267B2Beta-turn peptidomimetic cyclic compounds for treating dry eyeMIMETOGEN PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →